Literature DB >> 27913645

IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.

Esil Aleyd1, Marjon Al2, Cornelis W Tuk1, Conny J van der Laken2, Marjolein van Egmond3,4.   

Abstract

Autoantibodies, including rheumatoid factor (RF), are an important characteristic of rheumatoid arthritis (RA). Interestingly, several studies reported a correlation between the presence of IgA autoantibodies and worse disease course. We demonstrated previously that triggering the IgA Fc receptor (FcαRI) on neutrophils results in neutrophil recruitment and the release of neutrophil extracellular traps (NETs). Because this can lead to tissue damage, we investigated whether IgA immune complexes in plasma and synovial fluid of RA patients activate neutrophils. RF isotypes were measured with ELISA, and immune complexes were precipitated using polyethylene glycol 6000. Isolated neutrophils were incubated with immune complexes, and activation and release of NETs were determined in the presence or absence of FcαRI-blocking Abs. Plasma and SF of RA patients contained IgM, IgG, and IgA RFs. Patient plasma IgA RF and IgM RF showed a strong correlation. No uptake of IgM and minimal endocytosis of IgG immune complexes by neutrophils was observed, in contrast to avid uptake of IgA complexes. Incubation of neutrophils with immune complexes resulted in the production of reactive oxygen species, as well as the release of NETs, lactoferrin, and chemotactic stimuli. Importantly, activation of neutrophils was reduced when FcαRI was blocked. Neutrophils were activated by IgA immune complexes, which suggests that neutrophils play a role in inducing joint damage in RA patients who have IgA autoantibody complexes, thereby increasing the severity of disease. Blocking FcαRI inhibited neutrophil activation and, as such, may represent an additional attractive novel therapeutic strategy for the treatment of RA.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27913645     DOI: 10.4049/jimmunol.1502353

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity.

Authors:  Niels Heemskerk; Mandy Gruijs; A Robin Temming; Marieke H Heineke; Dennis Y Gout; Tessa Hellingman; Cornelis W Tuk; Paula J Winter; Suzanne Lissenberg-Thunnissen; Arthur Eh Bentlage; Marco de Donatis; Marijn Bögels; Thies Rösner; Thomas Valerius; Jantine E Bakema; Gestur Vidarsson; Marjolein van Egmond
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 2.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

3.  A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients With Rheumatoid Arthritis.

Authors:  Mary Bach; Jeonghun Moon; Richard Moore; Tiffany Pan; J Lee Nelson; Christian Lood
Journal:  Arthritis Rheumatol       Date:  2019-12-03       Impact factor: 10.995

4.  Antibody Responses to Citrullinated and Noncitrullinated Antigens in the Sputum of Subjects With Rheumatoid Arthritis and Subjects at Risk for Development of Rheumatoid Arthritis.

Authors:  M Kristen Demoruelle; Emily Bowers; Lauren J Lahey; Jeremy Sokolove; Monica Purmalek; Nickie L Seto; Michael H Weisman; Jill M Norris; Mariana J Kaplan; V Michael Holers; William H Robinson; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2018-03-02       Impact factor: 10.995

5.  Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis.

Authors:  Bhargavi Duvvuri; Al Anoud Baddour; Kevin D Deane; Marie L Feser; J Lee Nelson; M Kristen Demoruelle; Christian Lood
Journal:  J Autoimmun       Date:  2021-03-10       Impact factor: 7.094

6.  IgA potentiates NETosis in response to viral infection.

Authors:  Hannah D Stacey; Diana Golubeva; Alyssa Posca; Jann C Ang; Kyle E Novakowski; Muhammad Atif Zahoor; Charu Kaushic; Ewa Cairns; Dawn M E Bowdish; Caitlin E Mullarkey; Matthew S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

7.  IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus.

Authors:  Christian Lood; Tomas Mustelin; Kennedy C Ukadike; Kathryn Ni; Xiaoxing Wang; Martin S Taylor; John LaCava; Lauren M Pachman; Mary Eckert; Anne Stevens
Journal:  Arthritis Res Ther       Date:  2021-05-29       Impact factor: 5.156

8.  IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption.

Authors:  Annelot C Breedveld; Melissa M J van Gool; Myrthe A M van Delft; Conny J van der Laken; Teun J de Vries; Ineke D C Jansen; Marjolein van Egmond
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

9.  Neutrophil Extracellular Traps are Present in Immune-complex-mediated Cutaneous Small Vessel Vasculitis and Correlate with the Production of Reactive Oxygen Species and the Severity of Vessel Damage.

Authors:  Christina Bergqvist; Rémi Safi; George El Hasbani; Ossama Abbas; Abdulghani Kibbi; Dany Nassar
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

10.  Human neutrophil FcγRIIIb regulates neutrophil extracellular trap release in response to electrospun polydioxanone biomaterials.

Authors:  Allison E Fetz; Marko Z Radic; Gary L Bowlin
Journal:  Acta Biomater       Date:  2021-06-09       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.